by Chris Bodenner
A reader keeps the thread going:
The Susan G. Komen Foundation certainly has become a marketing phenomenon. In 2011, SGK released their own perfume – "Promise Me" (pink, of course). The big surprise though is that one of the ingredients has been associated with breast cancer:
Before going public with their findings, [Breast Cancer Action] executive director Karuna Jaggar sent a letter to Komen, asking them to pull the perfume from store shelves. The foundation's response was oddly contradictory. On the one hand, it was dismissive, claiming that "our Medical and Scientific Affairs team has thoroughly reviewed and evaluated current research about the perfume ingredients…and concluded that these ingredients do not elevate breast cancer risk in humans." Despite this position, however, Komen also agreed to "reformulate the perfume to remove any doubt about the ingredients.
Although SGK agreed to reformulate the perfume, it won't be available until sometime this year. Meanwhile, the original formula is available at retailers.
Before going public with their findings, [Breast Cancer Action] executive director Karuna Jaggar sent a letter to Komen, asking them to pull the perfume from store shelves. The foundation's response was oddly contradictory. On the one hand, it was dismissive, claiming that "our Medical and Scientific Affairs team has thoroughly reviewed and evaluated current research about the perfume ingredients…and concluded that these ingredients do not elevate breast cancer risk in humans." Despite this position, however, Komen also agreed to "reformulate the perfume to remove any doubt about the ingredients.